SENORES PHARMACEUTICALS LIMITED — Call Transcript 2025

Oct 29, 2025

==> picture [151 x 20] intentionally omitted <==

==> picture [151 x 20] intentionally omitted <==

Date: October 29, 2025

To, Sr. General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 BSE Scrip Code: 544319

To, Sr. General Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051 NSE Symbol: SENORES

Dear Sir/Madam,

Sub.: Intimation for Earnings Conference Call for Q2FY26

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that, post announcement of Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025, the Company will hold the earnings conference call for Q2FY26 on Thursday, November 06, 2025, at 05:00 P.M. (IST).

The details of the aforesaid earnings conference call are annexed herewith.

The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly.

You are requested to take the same on record.

Thanking you.

For Senores Pharmaceuticals Limited

Vinay Kumar Digitally signed by Vinay Kumar Mishra Mishra Date: 2025.10.29 18:04:33 +05'30'

Vinay Kumar Mishra

Company Secretary and Compliance Officer ICSI Membership No.: F11464

Enclosures: As above

Senores Pharmaceuticals Limited

1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India

P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263

==> picture [127 x 66] intentionally omitted <==

Q2FY26 Earnings Call Senores Pharmaceuticals Limited November 06, 2025 at 5:00 pm (IST)

==> picture [158 x 40] intentionally omitted <==

Ambit Capital cordially invites you to the Q2FY26 Earnings Call of Senores Pharmaceuticals Limited

Company Representatives

Mr. Swapnil Shah – Managing Director Mr. Sanjay Majmudar – Chairman Mr. Deval Shah – Chief Financial Officer

The teleconference will be moderated by Pranav Chawla, Institutional Equities, Ambit Capital. Conference Call Details

Date: November 06, 2025 | Time: 5:00 pm (IST)

Please join the conference via Diamond Pass to avoid wait time. Pleaseclick here to register.	Please join the conference via Diamond Pass to avoid wait time. Pleaseclick here to register.
Primary Access Numbers	+91 22 6280 1148 +91 22 7115 8049
International Toll Free Numbers	Singapore:800 101 2045
	HongKong:800 964 448
	USA:1 866 746 2133
	UK:0 808 101 1573
We requestyou to dial in a few minutesprior to the scheduled time.